TG693 is used in pharmaceutical research and development, particularly for treating neurological disorders such as Alzheimer's and Parkinson's disease. It exhibits properties that enhance neuronal cell function and reduce brain inflammation. Additionally, studies explore its application in treating certain cancers, focusing on inhibiting cancer cell growth and inducing programmed cell death (apoptosis). Research remains in the experimental phase, but initial results indicate potential for future therapeutic drug development.